These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Protection against experimental visceral leishmaniasis infection in dogs immunized with purified excreted secreted antigens of Leishmania infantum promastigotes. Lemesre JL; Holzmuller P; Cavaleyra M; Gonçalves RB; Hottin G; Papierok G Vaccine; 2005 Apr; 23(22):2825-40. PubMed ID: 15780731 [TBL] [Abstract][Full Text] [Related]
5. Humoral responses following immunization with Leishmania infantum (ex. Oklahoma): a comparison of adjuvant efficacy in the antibody responses of Balb-C mice. Lasarow RM; Williams DL; Theis JH Int J Immunopharmacol; 1992 Jul; 14(5):767-72. PubMed ID: 1512073 [TBL] [Abstract][Full Text] [Related]
6. Leishmania donovani recombinant iron superoxide dismutase B1 protein in the presence of TLR-based adjuvants induces partial protection of BALB/c mice against Leishmania major infection. Daifalla NS; Bayih AG; Gedamu L Exp Parasitol; 2012 Jul; 131(3):317-24. PubMed ID: 22580023 [TBL] [Abstract][Full Text] [Related]
7. Gentamicin-attenuated Leishmania infantum: a clinicopathological study in dogs. Daneshvar H; Molaei MM; Afshar RM; Kamiabi H; Burchmore R; Hagan P; Phillips RS Vet Immunol Immunopathol; 2009 May; 129(1-2):28-35. PubMed ID: 19147233 [TBL] [Abstract][Full Text] [Related]
8. Non PC liposome entrapped promastigote antigens elicit parasite specific CD8+ and CD4+ T-cell immune response and protect hamsters against visceral leishmaniasis. Sharma SK; Dube A; Nadeem A; Khan S; Saleem I; Garg R; Mohammad O Vaccine; 2006 Mar; 24(11):1800-10. PubMed ID: 16310900 [TBL] [Abstract][Full Text] [Related]
9. Prophylactic immunization against experimental Leishmania donovani infection by use of a purified protein vaccine. White AC; McMahon-Pratt D J Infect Dis; 1990 Jun; 161(6):1313-4. PubMed ID: 2345310 [No Abstract] [Full Text] [Related]
10. Leishmania donovani serine protease encapsulated in liposome elicits protective immunity in experimental visceral leishmaniasis. Das P; Paik D; Naskar K; Chakraborti T Microbes Infect; 2018 Jan; 20(1):37-47. PubMed ID: 28970116 [TBL] [Abstract][Full Text] [Related]
11. The FML-vaccine (Leishmune) against canine visceral leishmaniasis: a transmission blocking vaccine. Saraiva EM; de Figueiredo Barbosa A; Santos FN; Borja-Cabrera GP; Nico D; Souza LO; de Oliveira Mendes-Aguiar C; de Souza EP; Fampa P; Parra LE; Menz I; Dias JG; de Oliveira SM; Palatnik-de-Sousa CB Vaccine; 2006 Mar; 24(13):2423-31. PubMed ID: 16386824 [TBL] [Abstract][Full Text] [Related]
12. Vaccination with plasmid DNA encoding KMPII, TRYP, LACK and GP63 does not protect dogs against Leishmania infantum experimental challenge. Rodríguez-Cortés A; Ojeda A; López-Fuertes L; Timón M; Altet L; Solano-Gallego L; Sánchez-Robert E; Francino O; Alberola J Vaccine; 2007 Nov; 25(46):7962-71. PubMed ID: 17942199 [TBL] [Abstract][Full Text] [Related]
13. Vaccination of dogs with six different candidate leishmaniasis vaccines composed of a chimerical recombinant protein containing ribosomal and histone protein epitopes in combination with different adjuvants. Poot J; Janssen LH; van Kasteren-Westerneng TJ; van der Heijden-Liefkens KH; Schijns VE; Heckeroth A Vaccine; 2009 Jul; 27(33):4439-46. PubMed ID: 19500553 [TBL] [Abstract][Full Text] [Related]
14. Vaccination trial against canine visceral leishmaniasis. Phocean Veterinary Study Group on Visceral Leishmaniasis. Dunan S; Frommel D; Monjour L; Ogunkolade BW; Cruz A; Quilici M Parasite Immunol; 1989 Jul; 11(4):397-402. PubMed ID: 2780090 [TBL] [Abstract][Full Text] [Related]
15. A Leishmania-specific hypothetical protein expressed in both promastigote and amastigote stages of Leishmania infantum employed for the serodiagnosis of, and as a vaccine candidate against, visceral leishmaniasis. Martins VT; Duarte MC; Chávez-Fumagalli MA; Menezes-Souza D; Coelho CS; de Magalhães-Soares DF; Fernandes AP; Soto M; Tavares CA; Coelho EA Parasit Vectors; 2015 Jul; 8():363. PubMed ID: 26160291 [TBL] [Abstract][Full Text] [Related]
16. Protection of mice against visceral leishmaniasis by immunization with promastigote antigen incorporated in liposomes. Ali N; Afrin F J Parasitol; 1997 Feb; 83(1):70-5. PubMed ID: 9057699 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of the immunoprophylactic potential of a killed vaccine candidate in combination with different adjuvants against murine visceral leishmaniasis. Thakur A; Kaur H; Kaur S Parasitol Int; 2015 Feb; 64(1):70-8. PubMed ID: 25316605 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of the immunogenicity and protective efficacy of killed Leishmania donovani antigen along with different adjuvants against experimental visceral leishmaniasis. Thakur A; Kaur H; Kaur S Med Microbiol Immunol; 2015 Aug; 204(4):539-50. PubMed ID: 25432859 [TBL] [Abstract][Full Text] [Related]
19. Studies on the protective efficacy of freeze thawed promastigote antigen of Leishmania donovani along with various adjuvants against visceral leishmaniasis infection in mice. Thakur A; Kaur H; Kaur S Immunobiology; 2015 Sep; 220(9):1031-8. PubMed ID: 26001730 [TBL] [Abstract][Full Text] [Related]
20. Dogs vaccinated with gentamicin-attenuated Leishmania infantum or infected with wild-type parasite can be distinguished by Western blotting. Daneshvar H; Mahmmodi Z; Kamiabi H; Phillips RS; Burchmore R Parasite Immunol; 2014 May; 36(5):218-24. PubMed ID: 24611833 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]